Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4210
Gene Symbol: MEFV
MEFV
0.010 Biomarker disease BEFREE Pop-eyelid and eyelash ptosis were observed in 8% of patients operated with FMF. 29659435 2019
Entrez Id: 7471
Gene Symbol: WNT1
WNT1
0.010 Biomarker disease BEFREE Thorough revision of the clinical symptoms of these 10 novel patients and previously published AR WNT1 OI cases highlight ptosis as a unique hallmark in the diagnosis of this OI subtype. 30896082 2019
Entrez Id: 146
Gene Symbol: ADRA1D
ADRA1D
0.010 Biomarker disease BEFREE Because apraclonidine has an α-1 agonistic effect, α-1D adrenoceptor may contribute to apraclonidine's elevating effect in patients with blepharoptosis. 29634605 2019
Entrez Id: 4566
Gene Symbol: TRNK
TRNK
0.010 GeneticVariation disease BEFREE The first patient, a 44-year-old woman, had bilateral eyelid ptosis and the m.8305C>T mutation in the MTTK gene. 29174468 2018
Entrez Id: 4810
Gene Symbol: NHS
NHS
0.010 Biomarker disease BEFREE PurposeCorrection of upper eyelid ptosis is one of the most commonly performed oculoplastic procedures on the NHS but there is currently no data in the literature informing the surgeon of the optimal time for the first postoperative review. 29328065 2018
Entrez Id: 378938
Gene Symbol: MALAT1
MALAT1
0.010 Biomarker disease BEFREE Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy. 29439314 2018
Entrez Id: 4128
Gene Symbol: MAOA
MAOA
0.010 AlteredExpression disease BEFREE In addition, IRN treatment antagonized reserpine-induced ptosis and significantly enhanced the levels of monoamine neurotransmitters including norepinephrine (NE) and 5-hydroxytryptamine (5-HT), and the activity of monoamine oxidase A (MAO-A) in the hippocampus and frontal cortex of mice. 27900600 2017
Entrez Id: 5617
Gene Symbol: PRL
PRL
0.010 Biomarker disease BEFREE In vivo studies measuring ptosis and prolactin secretion in the rat confirmed the specific and dose-dependent interactions of tetrabenazine and R,R,R-HTBZ with VMAT2. 28404690 2017
Entrez Id: 27335
Gene Symbol: EIF3K
EIF3K
0.010 Biomarker disease BEFREE Two months after delivery, the mother developed ptosis and generalized symptoms and subsequent workup revealed she was muscle specific kinase (MuSK) antibody positive. 28495046 2017
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.010 GeneticVariation disease BEFREE We propose that the PIK3CB gene included in our patient's chromosome 3q deletion may be the gene responsible for microcephaly and other patients with blepharophimosis-ptosis-epicanthus inversus syndrome because of a chromosome 3q deletion. 24725350 2014
Entrez Id: 57132
Gene Symbol: CHMP1B
CHMP1B
0.010 GeneticVariation disease BEFREE Although the incidental association of OT and C10orf2 TWINKLE mutation is possible, the simultaneous onset of OT and eyelid ptosis at a much younger age than usually observed for OT raises the possibility of mitochondrial dysfunction and loss of mitochondrial DNA integrity in the pathogenesis of OT. 24061067 2013
Entrez Id: 9048
Gene Symbol: ARTN
ARTN
0.010 GeneticVariation disease BEFREE We demonstrate its use in identifying ARTN as a strong candidate gene within the 1p34.1-p32 mapped locus for a hereditary form of ptosis. 22331800 2012
Entrez Id: 84107
Gene Symbol: ZIC4
ZIC4
0.010 GeneticVariation disease BEFREE De novo interstitial deletion of 3q22.3-q25.2 encompassing FOXL2, ATR, ZIC1, and ZIC4 in a patient with blepharophimosis/ptosis/epicanthus inversus syndrome, Dandy-Walker malformation, and global developmental delay. 21471554 2011
Entrez Id: 79776
Gene Symbol: ZFHX4
ZFHX4
0.010 Biomarker disease BEFREE Human ZFH-4 is therefore a candidate gene for congenital bilateral isolated ptosis. 11935336 2002
Entrez Id: 401
Gene Symbol: PHOX2A
PHOX2A
0.010 GeneticVariation disease BEFREE (4,5) Individuals with CFEOM2 are born with bilateral ptosis and exotropia. 11960793 2002
Entrez Id: 2181
Gene Symbol: ACSL3
ACSL3
0.010 GeneticVariation disease BEFREE Saethre-Chotzen syndrome (acrocephalo-syndactyly type III, ACS III) is an autosomal dominant craniosynostosis with brachydactyly, soft tissue syndactyly and facial dysmorphism including ptosis, facial asymmetry and prominent ear crura. 8988167 1997
Entrez Id: 4974
Gene Symbol: OMG
OMG
0.020 GeneticVariation disease BEFREE Twenty-two patients with OMG presenting with isolated ptosis or diplopia, who initially tested negative, were re-tested in relation to a worsening of their symptoms showing a positivisation in 91% of cases. 31734908 2020
Entrez Id: 4974
Gene Symbol: OMG
OMG
0.020 Biomarker disease BEFREE Most patients first present with extraocular symptoms (diplopia and/or ptosis), and in 15% of cases symptoms will remain restricted to only the extraocular muscles (ocular myasthenia gravis [OMG]). 31847046 2019
Entrez Id: 55605
Gene Symbol: KIF21A
KIF21A
0.040 GeneticVariation disease BEFREE We report familial segregation of hereditary total leuconychia (HTL) with ptosis and restriction of ocular motility due to congenital fibrosis of the extraocular muscles type 1 (CFEOM1) in three generations. 19489868 2009
Entrez Id: 55605
Gene Symbol: KIF21A
KIF21A
0.040 AlteredExpression disease BEFREE Four families were clinically classified as having CFEOM type 1 (CFEOM1) with full expression of severe ptosis and ophthalmoplegia. 18332320 2008
Entrez Id: 55605
Gene Symbol: KIF21A
KIF21A
0.040 Biomarker disease BEFREE Subjects with CFEOM1 had severe bilateral blepharoptosis, limited supraduction, and variable ophthalmoplegia. 15671279 2005
Entrez Id: 55605
Gene Symbol: KIF21A
KIF21A
0.040 Biomarker disease BEFREE Individuals with CFEOM1 are born with bilateral ptosis and both eyes fixed in a downward position with absent upgaze and aberrant horizontal gaze. 11960793 2002
Entrez Id: 55777
Gene Symbol: MBD5
MBD5
0.090 Biomarker disease BEFREE Secondary outcome was overall mean change in MRD1 and the incidence of ptosis as defined by a final MRD1 ≤ 2.5 mm. 30908469 2020
Entrez Id: 9904
Gene Symbol: RBM19
RBM19
0.090 Biomarker disease BEFREE Secondary outcome was overall mean change in MRD1 and the incidence of ptosis as defined by a final MRD1 ≤ 2.5 mm. 30908469 2020
Entrez Id: 55777
Gene Symbol: MBD5
MBD5
0.090 Biomarker disease BEFREE Mechanical (involuntary) brow elevation significantly raised MRD1 in control eyelids and eyelids with dermatochalasis, but not in eyelids with ptosis. 30124610 2019